FDA Sticks Breakthrough Tag on GlaxoSmithKline's Blood Cancer Drug Post author:Sam Post published:November 1, 2017 Post category:BioPharma GSK2857916 is an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. Source: BioSpace You Might Also Like Dova Pharma Announces Pricing Of Initial Public Offering June 28, 2017 5 Things Illumina's Management Wants You to Know February 1, 2017 Zenosense: MIDS Quantitative Testing Results March 12, 2017
